Company Filing History:
Years Active: 2024-2025
Title: Innovations by Yuan-Hao Liu in Neutron Capture Therapy
Introduction
Yuan-Hao Liu is a prominent inventor based in Fujian, China, known for his significant contributions to the field of neutron capture therapy. With a total of four patents to his name, Liu has been at the forefront of developing advanced medical technologies aimed at improving cancer treatment.
Latest Patents
Liu's latest patents include a neutron capture therapy system designed to enhance the heat dissipation performance of target materials used in particle beam generation apparatuses. This innovative system comprises a neutron generation apparatus and a beam shaping body, where the neutron generation apparatus includes an accelerator and a target material. The charged particle beam generated by the accelerator interacts with the target material to produce a neutron beam. The target material is composed of several layers, including an active layer that generates the neutron beam, an anti-foaming layer that suppresses foaming, a heat dissipation layer that conducts heat rapidly, and a heat conduction layer that discharges heat using a cooling medium. Another notable patent is the neutron dose measurement apparatus and neutron capturing treatment device, which features a measurement unit for receiving neutrons, a signal processing unit, a counter for counting signals, and a count rate correction unit.
Career Highlights
Liu is currently associated with Neuboron Therapy System Ltd., where he continues to innovate and develop cutting-edge technologies in the medical field. His work has garnered attention for its potential to revolutionize cancer treatment through improved neutron capture techniques.
Collaborations
Liu collaborates with notable colleagues, including Chun-ting Lin and Chao Wang, who contribute to the research and development efforts at Neuboron Therapy System Ltd.
Conclusion
Yuan-Hao Liu's innovative work in neutron capture therapy exemplifies the potential of advanced medical technologies to improve treatment outcomes for cancer patients. His patents reflect a commitment to enhancing therapeutic techniques and demonstrate the importance of collaboration in scientific advancements.